The global animal healthcare market size is expected to reach around US$ 76.82 billion by 2030 from US$ 53.15 billion in 2021 and is expected to grow at an impressive double-digit rate of 4.2% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global animal healthcare market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1621
Report Scope of the Animal Healthcare Market
| Report Coverage | Details |
| Market Size by 2030 | USD 76.82 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 4.2% |
| North America Market Share in 2021 | 30% |
| Pharmaceutical Market Share in 2021 | 34% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
The animal health care market is care provided to mostly to domestic and pet animals. The growing prevalence of diseases among animals is creating lucrative opportunities for the growth of the global animal health care market during the forecast period. Furthermore, the expansion of online sales channel is also driving the demand for the market. The key players operating in the global animal health care market are continuously striving for the expansion of their market. For this, they are investing in research and development activities for launching new and innovative products in the animal health care market.
The demand for good food for pet animals is rising. This has resulted into increased in demand for pet food for animals. The major consumer goods companies and firms are launching new product line in animal health care products which includes pet food, pet milk, and pet accessories. The major market players are launching medications and vaccines for the treatment of animals on a large scale. The animals get infected very easily. To avoid such circumstances, animals are vaccinated periodically. As a result, major market players are launching vaccines that will protect animals from certain kind of viruses and pathogens.
In addition, the animal health care market is expanding due to rising government and non-governmental organizations’ initiatives for the promotion and campaigns for the animal health care. Various projects have been launched by governments of various regions in favor of animal health care. All of these aforementioned factors are boosting the growth of the global animal health care market during the forecast period.
Report Highlights:
- Based on the product, the pharmaceutical segment dominated the global animal healthcare market in 2021 with largest market share 34%. The factors contributing to an exponential rise in illness frequency have prompted companies to develop enhanced vaccines and medications, which is driving up demand for this market.
- Based on the end use, the veterinary hospitals and clinics segment dominated the global animal healthcare market in 2021 with largest market share 73.5%. The increasing demand and supply of vaccines, medications, and medicated feed additives, as well as the rising occurrence of zoonotic diseases, expanding feed output, and greater consumer awareness, all contribute to this segment’s growth.
- North America is the largest segment for animal healthcare market in terms of region and garnered 30% in 2021. Major corporations have collaborated to improve their research and development skills and assure high-quality standards, which is expected to drive demand even higher across the region. The majority of the share can also be linked to the region’s high disease burden.
- Asia-Pacific region is the fastest growing region in the animal healthcare market. The exponential increase can also be attributed to rising pet nutrition and supply awareness, as well as rising disposable income levels in Asia-Pacific’s emerging economies.
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global animal healthcare market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global animal healthcare market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global animal healthcare market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for animal healthcare are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global animal healthcare market include:
- Elanco
- Bayer
- Dechra Pharmaceuticals
- Neogen
- Boehringer Ingelheim
- Merck & Co, Inc.
- Zoetis
- Nutreco N.V.
- Virbac
- Vetquinol S.A.
Market Segmentation:
By Animal Type
- Production Animal
- Poultry
- Swine
- Cattle
- Fish
- Others
- Companion Animal
- Dogs
- Cats
- Horses
- Others
By Product
- Vaccines
- Live Attenuated Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- Others
- Pharmaceuticals
- Parasiticides
- Anti-infective
- Anti-inflammatory
- Analgesics
- Others
- Feed Additives
- Diagnostics
- Instruments
- Consumables
- Equipment and Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
By Distribution Channel
- Retail Pharmacy
- E-commerce
- Hospital Pharmacy
By End Use
- Reference Laboratories
- Point of care testing/ in-house testing
- Veterinary Hospitals & Clinics
- Others
By Treatments
- Allergies
- Arthritis
- Difficult Dermatology Cases
- Gastrointestinal Disease
- Others
Regional Analysis:
The geographical analysis of the global animal healthcare market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global animal healthcare Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global animal healthcare market in 2030?
- What is the expected CAGR for the animal healthcare market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global animal healthcare market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Healthcare Market
5.1. COVID-19 Landscape: Animal Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Healthcare Market, By Animal Type
8.1. Animal Healthcare Market, by Animal Type, 2022-2030
8.1.1. Production Animal
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Companion Animal
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Animal Healthcare Market, By Product Type
9.1. Animal Healthcare Market, by Product Type, 2022-2030
9.1.1. Vaccines
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Pharmaceuticals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Feed Additives
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Diagnostics
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Equipment and Disposables
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Animal Healthcare Market, By Distribution Channel
10.1. Animal Healthcare Market, by Distribution Channel Type, 2022-2030
10.1.1. Retail Pharmacy
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. E-commerce
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Hospital Pharmacy
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Animal Healthcare Market, By End Use
11.1. Animal Healthcare Market, by End Use Type, 2022-2030
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Point of care testing/ in-house testing
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Animal Healthcare Market, By Treatments Type
12.1. Animal Healthcare Market, by Treatments, 2022-2030
12.1.1. Allergies
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Arthritis
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Gastrointestinal Disease
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Difficult Dermatology Cases
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Animal Healthcare Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.4. Market Revenue and Forecast, by End Use (2017-2030)
13.1.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Animal (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)
13.1.7. Market Revenue and Forecast, by Treatments (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End Use (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.4. Market Revenue and Forecast, by End Use (2017-2030)
13.2.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Animal (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.7. Market Revenue and Forecast, by End Use (2017-2030)
13.2.8. Market Revenue and Forecast, by Treatments (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Animal (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.10. Market Revenue and Forecast, by End Use (2017-2030)
13.2.11. Market Revenue and Forecast, by Treatments (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Animal (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End Use (2017-2030)
13.2.13. Market Revenue and Forecast, by Treatments (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Animal (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End Use (2017-2030)
13.2.15. Market Revenue and Forecast, by Treatments (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.4. Market Revenue and Forecast, by End Use (2017-2030)
13.3.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Animal (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)
13.3.7. Market Revenue and Forecast, by Treatments (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)
13.3.9. Market Revenue and Forecast, by Treatments (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Animal (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End Use (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Animal (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End Use (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.4. Market Revenue and Forecast, by End Use (2017-2030)
13.4.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Animal (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)
13.4.7. Market Revenue and Forecast, by Treatments (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)
13.4.9. Market Revenue and Forecast, by Treatments (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Animal (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End Use (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Animal (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End Use (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.4. Market Revenue and Forecast, by End Use (2017-2030)
13.5.5. Market Revenue and Forecast, by Treatments (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Animal (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)
13.5.7. Market Revenue and Forecast, by Treatments (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End Use (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Treatments (2017-2030)
Chapter 14. Company Profiles
14.1. Elanco
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bayer
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Dechra Pharmaceuticals
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Neogen
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Boehringer Ingelheim
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Merck & Co, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Zoetis
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nutreco N.V.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Virbac
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Vetquinol S.A.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1621
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments